Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | |
| Operating Expenses | 12,952 | 0 |
| Operating Income | -12,952 | N/A |
| Other Income | -69 | 0 |
| Pre-tax Income | -13,021 | 0 |
| Income Tax | 60 | N/A |
| Net Income Continuous | -13,081 | N/A |
| Net Income | $-13,081 | $N/A |
| EPS Basic Total Ops | -4.33 | N/A |
| EPS Basic Continuous Ops | -4.33 | N/A |
| EPS Diluted Total Ops | -4.33 | N/A |
| EPS Diluted Continuous Ops | -4.33 | N/A |
| EBITDA(a) | $-12,899 | $N/A |